MEDICOX Management

Management Kriterienprüfungen 0/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Byungchul Jun

Geschäftsführender

n/a

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	n/a
Amtszeit als Geschäftsführer	no data
Eigentum des Geschäftsführers	n/a
Durchschnittliche Amtszeit des Managements	keine Daten
Durchschnittliche Amtszeit der Vorstandsmitglieder	keine Daten

Jüngste Management Updates

Recent updates

Some Confidence Is Lacking In MEDICOX Co., Ltd. (KOSDAQ:054180) As Shares Slide 35%

Sep 20

Revenues Not Telling The Story For MEDICOX Co., Ltd. (KOSDAQ:054180) After Shares Rise 40%

Jul 02

Geschäftsführer

Byungchul Jun

no data

Amtszeit

Mr. Byungchul Jun serves as the Chief Executive Officer and President at MEDICOX Co., Ltd. (formerly known as ChoongAng Ocean Co., Ltd.).

MEDICOX Management

Management Kriterienprüfungen 0/4

Wichtige Informationen

Jüngste Management Updates

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Some Confidence Is Lacking In MEDICOX Co., Ltd. (KOSDAQ:054180) As Shares Slide 35%

New major risk - Financial data availability

MEDICOX Co., Ltd. has completed a Follow-on Equity Offering in the amount of KRW 999.999585 million.

MEDICOX Co., Ltd. has filed a Follow-on Equity Offering in the amount of KRW 999.999585 million.

Revenues Not Telling The Story For MEDICOX Co., Ltd. (KOSDAQ:054180) After Shares Rise 40%

New minor risk - Share price stability

Is MEDICOX (KOSDAQ:054180) Using Debt In A Risky Way?

Full year 2023 earnings released: ₩1,004 loss per share (vs ₩1,979 loss in FY 2022)

New major risk - Share price stability

New major risk - Shareholder dilution

MEDICOX Co., Ltd. announced that it has received KRW 3.99999852 billion in funding

MEDICOX Co., Ltd. announced that it expects to receive KRW 17.999998883 billion in funding from Guwol Partners Co. , Ltd.

MEDICOX Co., Ltd. announced that it expects to receive KRW 999.99738 million in funding from Nowinvestment. Co. Ltd, Cereal Co., Ltd.

MEDICOX Co., Ltd. announced that it expects to receive KRW 9.9999977 billion in funding

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

MEDICOX Co., Ltd. announced that it has received KRW 5 billion in funding from Sangsangin Savings Bank, Investment Arm

An unknown buyer agreed to acquire 5.99% stake in Connec Co. Ltd. from MEDICOX Co., Ltd. (KOSDAQ:A054180) for KRW 11.2 billion.

MEDICOX Co., Ltd. announced that it has received KRW 20 billion in funding from Baro Savings Bank, Sangsangin Plus Savings Bank, Investment Arm, Sangsangin Savings Bank, Investment Arm

MEDICOX Co., Ltd. announced that it expects to receive KRW 20 billion in funding from Baro Savings Bank, Sangsangin Plus Savings Bank, Investment Arm, Sangsangin Savings Bank, Investment Arm

Would MEDICOX (KOSDAQ:054180) Be Better Off With Less Debt?

MEDICOX (KOSDAQ:054180) Share Prices Have Dropped 71% In The Last Three Years

Full year 2020 earnings released: ₩248 loss per share (vs ₩135 loss in FY 2019)

New 90-day low: ₩1,465

New 90-day low: ₩1,490

New 90-day low: ₩1,660

New 90-day high: ₩3,045

MEDICOX Co., Ltd. announced that it expects to receive KRW 5 billion in funding

New 90-day high: ₩1,945

ChoongAng Ocean Co., Ltd. (KOSDAQ:A054180) acquired an additional 21.4% stake in Mecox Curemed Co., Ltd. from Jung, Jae Yong and K Clavis Meister New Technology Association No. Sixty for KRW 12.1 billion.

ChoongAng Ocean Co., Ltd. announced that it has received KRW 12.099999764 billion in funding

New 90-day low - ₩1,035

ChoongAng Ocean Co., Ltd. announced that it expects to receive KRW 12.099999764 billion in funding

ChoongAng Ocean Co., Ltd. announced that it has received KRW 15.996 billion in funding from Seagate Co., Ltd., New Company Co., Ltd.

Geschäftsführer

Amtszeit